CEH Funded Grants

Grants Awarded Through Support from CEH Donors

  • A pilot study of intratumoral injections of interleukin-2 (IL-2) for equine melanomas
  • Delivery of Exogenous EGR1 mRNA to Improve Tendon Formation
  • Incorporating long-read sequencing technology to improve the equine neuroepigenetic atlas
  • Evaluation of Vincristine Chemotherapy for the Treatment of Lymphomas in Horses
  • Diagnostic and prognostic value of serial measurements of procalcitonin and sCD14+ in septic neonatal foals
  • Pharmacokinetics and biocompatibility of a novel cyclosporine-loaded microsphere thermo-responsive hydrogel drug delivery system in horses
  • Pain assessment during and after TVA in mares using epidural and injectable analgesics
  • Machine supported interpretation of laboratory data from diseased horses using unsupervised learning
  • PET imaging of the racehorse fetlock after surgical repair of fracture 
  • Promoting tendon formation with dipeptide prolyl‐hydroxyproline
  • Validating the genetic cause for equine juvenile spinocerebellar ataxia
  • Embryo-maternal communication in mares during pre-implantation (fixation) period
  • Determining the association between EHV-4 viral shedding and environmental contamination
  • Using spatial transcriptomics to diagnose causes of non-infectious neurologic disease in the horse
  • Thermal nociceptive effects of oral morphine in horses
  • Exploring bacterial metabolite and gene expression during equine placentitis
  • Characterizing genetic loci associated with insidious uveitis in LP-spotted horse breeds
  • The influence of the reproductive cycle stage on equine endometrial organoid formation and function
  • Investigation of the detection frequency of respiratory pathogens in healthy sport horses and their environment during the Traverse City horse show period
  • Pharmacokinetics of oral marbofloxacin in adult horses
  • Distribution of alprazolam into the milk of lactating mares and subsequent absorption by nursing foals
  • Pharmacokinetics and safety of oral fluralaner at 10 and 25 mg/kg in the horse
  • Evaluation of the feasibility of a cardiorespiratory screening protocol in the Thoroughbred Racehorse
  • Defining metabolic status in mules creating references ranges related to metabolic disease
  • Investigation of genetic susceptibility for chronic progressive lymphedema in draft horses
  • Effect of ertugliflozin, a sodium-glucose cotransporter-2 inhibitor, on dexamethasone-induced insulin dysregulation in healthy horses
  • Development of a high-fidelity model for puncture of atlanto-occipital site
  • Do endometrial organoids resemble in vivo conditions? Effects of steroids on equine endometrial organoids
  • X-chromosome inactivation in equine placenta and fetal tissues
  • Long-range sequencing for equine neuroaxonal dystrophy (eNAD)
  • Optimization of transdermal buprenorphine administration to horses
  • Characterization of a novel treatment for gastric ulcers in horses
  • Mitigating the adverse effects of Diclofenac on tendon cells with Vitamin C
  • Investigating the use of an air sampler for the detection of equine airborne respiratory pathogens
  • Quantitative microbial evaluation of Armatrex antimicrobial solution

*Information on completed projects can be found in the CEH Research Reviews publications.